Inhibition of the 53BP2S-mediated apoptosis by nuclear factor κB and Bcl-2 family proteins

Genes to Cells

Volumn 10, Issue 8, 2005, Pages 803-811

  Takahashi, Naoko ^a   Kobayashi, Shinya ^a   Kajino, Shinichi ^a   Imai, Kenichi ^a   Tomoda, Keisuke ^a   Shimizu, Shigeomi ^b   Okamoto, Takashi ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CASPASE 9; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BCL 2; PROTEIN P53;

APOPTOSIS; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; ENZYME ACTIVATION; GENE ACTIVATION; HUMAN; HUMAN CELL; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM;

APOPTOSIS; BENZIMIDAZOLES; CARRIER PROTEINS; CASPASE 9; CASPASES; CELL SURVIVAL; ECDYSTERONE; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GREEN FLUORESCENT PROTEINS; HUMANS; MODELS, BIOLOGICAL; NF-KAPPA B; ORGANIC CHEMICALS; PANCREATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 23844528539     PISSN: 13569597     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2443.2005.00878.x     Document Type: Article

References (30)

1. Ao, Y., Rohde, L.H. & Naumovski, L. (2001) p53-interacting protein 53BP2 inhibitsclonogenic survival and sensitizes cells to doxorubicin but not paclitaxel-induced apoptosis. Oncogene 20, 2720-2725.
2. Arlt, A., Vorndamm, J., Müerköster, S., et al. (2002) Autocrine production of interleukin 1beta confers constitutive nuclear factor κB activity and chemoresistance in pancreatic carcinoma cell lines. Cancer Res. 62, 910-916.
3. Asamitsu, K., Kanazawa, S., Tetsuka, T. & Okamoto, T. (2003) RING finger protein AO7 supports NF-kappaB-mediated transcription by interacting with the transactivation domain of the p65 subunit. J. Biol. Chem. 278, 26879-26887.
4. Bergamaschi, D., Samuels, Y., Jin, B., Duraisingham, S., Crook, T. & Lu, X. (2004) ASPP1 and ASPP2: common activators of p53 family members. Mol. Cell. Biol. 24, 1341-1350.
5. Bottero, V., Rossi, F., Samson, M., Mari, M., Hofman, P. & Peyron, J.F. (2001) IκBα, the NF-κB inhibitory subunit, interacts with ANT, the mitochondrial ATP/ADP translocator. J. Biol. Chem. 276, 21317-21324.
6. L. Mol. Cell. Biol. 20, 2687-2695.
7. Chen, F., Castranova, V. & Shi, X. (2001) New insights into the role of nuclear factor-κB in cell growth regulation. Am. J. Pathol. 159, 387-397.
8. Chu, Z.L., McKinsey, T.A., Liu, L., Gentry, J.J., Malim, M.H. & Ballard, D.W. (1997) Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-κB control. Proc. Natl. Acad. Sci. USA 94, 10057-10062.
9. Cogswell, P.C., Kashatus, D.F., Keifer, J.A., et al. (2003) NF-κB and IκBα are found in the mitochondria. Evidence for regulation of mitochondrial gene expression by NF-κB. J. Biol. Chem. 278, 2963-2968.
10. Daniel, N.N. & Korsmeyer, S.J. (2004) Cell death: critical control points. Cell 116, 205-219.
11. DeLuca, C., Kwon, H., Pelletier, N., Wainberg, M.A. & Hiscott, J. (1998) NF-κB protects HIV-1-infected Myeloid cells from apoptosis. Virology 244, 27-38.
12. Gorina, S. & Pavletich, N.P. (1996) Structure of the p53 tumor suppressor bound to the ankyrin and SH3 domains of 53BP2. Science 274, 1001-1005.
13. Haddad, J.J. (2004) On the antioxidation mechanisms of Bcl-2: a retrospective of NF-κB signaling and oxidative stress. Biochem. Biophys. Res. Commun. 322, 355-363.
14. Iwabuchi, K., Bartel, P.L., Li, B., Marraccino, R. & Fields, S. (1994) Two cellular proteins that bind to wild-type but not mutant p53. Proc. Natl. Acad. Sci. USA 91, 6098-6102.
15. Iwabuchi, K., Li, B., Massa, H.F., Trask, B.J., Date, T. & Fields, S. (1998) Stimulation of p53-meditated transcriptional activation by the p53-binding proteins, 53BP1 and 53BP2. J. Biol. Chem. 273, 26061-26068.
16. Kajino, S., Suganuma, M., Teranishi, F., et al. (2000) Evidence that de novo protein synthesis is dispensable for anti-apoptotic effects of NF-κB. Oncogene 19, 2233-2239.
17. Karin, M. & Lin, A. (2002) NF-κB at the crossroads of like and death. Nature Immunol. 3, 221-227.
18. Kobayashi, S., Kajino, S., Takahashi, N., et al. (2005) 53BP2 induces apoptosis through the mitochondrial death pathway. Genes Cells 3, 253-260.
19. Lopez, C.D., Ao, Y., Rohde, L.H., et al. (2000) Proapoptotic p53-interacting protein 53BP2 is induced by UV irradiation but suppressed by p53. Mol. Cell. Biol. 20, 8018-8025.
20. Mori, T., Okamoto, H., Takahashi, N., Ueda, R. & Okamoto, T. (2000) Aberrant overexpression of 53BP2 mRNA in lung cancer cell lines. FEBS Lett. 465, 124-128.
21. Naumovski, L. & Cleary, M.L. (1996) The p53-binding protein 53BP2 also interacts with Bc12 and impedes cell cycle progression at G2/M. Mol. Cell. Biol. 16, 3884-3892.
22. Samuels-Lev, Y., O'Connor, D.J., Bergamaschi, D., et al. (2001) ASPP proteins specifically stimulate the apoptotic function of p53. Mol. Cell 8, 781-794.
23. Shimizu, S., Eguchi, Y., Kamiike, W., et al. (1996) Bcl-2 blocks loss of mitochondrial membrane potential while ICE inhibitors act at a different step during inhibition of death induced by respiratory chain inhibitors. Oncogene 13, 21-29.
24. Shimizu, S., Konishi, A., Kodama, T. & Tsujimoto, Y. (2000) BH4 domain of antiapoptotic Bcl-2 family members closes voltage-dependent anion channel and inhibits apoptotic mitochondrial changes and cell death. Proc. Natl. Acad. Sci. USA 97, 3100-3105.
25. Takada, N., Sanda, T., Okamoto, H., et al. (2002) RelA-associated inhibitor blocks transcription of human immunodeficiency virus type1 by inhibiting NF-κB and Sp1 actions. J. Virol. 76, 8019-8030.
26. Takahashi, N., Kobayashi, S., Jiang, X., et al. (2004) Expression of 53BP2 and ASPP2 proteins from TP53BP2 gene by alternative splicing. Biochem. Biophys. Res. Commun. 315, 434-438.
27. Wu, M.X., Ao, Z., Prasad, K.V., Wu, R. & Schlossman, S.F. (1998) IEX-1L, an apoptosis inhibitor involved in NF-κB-mediated cell survival. Science 281, 998-1001.
28. Yang, J.P., Ono, T., Sonta, S., Kawabe, T. & Okamoto, T. (1997) Assignment of p53 binding protein (TP53BP2) to human chromosome band 1q42.1 by in situ hybridization. Cytogenet. Cell Genet. 78, 61-62.
29. Yang, J.P., Hori, M., Takahashi, N., Kawabe, T., Kato, H. & Okamoto, T. (1999) NF-κB subunit p65 binds to 53BP2 and inhibits cell death induced by 53BP2. Oncogene 18, 5177-5186.
30. Yoshikawa, H., Nagashima, M., Khan, M.A., McMenamin, M.G., Hagiwara, K. & Harris, C.C. (1999) Mutational analysis of p73 and p53 in human cancer cell lines. Oncogene 18, 3415-3421.